Cargando…

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why

Women with impaired ovarian reserve or poor ovarian response (POR) to exogenous gonadotropin stimulation present a challenge for reproductive specialists. The primary reasons relate to the still limited knowledge about the POR pathophysiology and the lack of practical solutions for the management of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Esteves, Sandro C., Roque, Matheus, Bedoschi, Giuliano M., Conforti, Alessandro, Humaidan, Peter, Alviggi, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107695/ https://www.ncbi.nlm.nih.gov/pubmed/30174650 http://dx.doi.org/10.3389/fendo.2018.00461

Ejemplares similares

Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
por: Esteves, Sandro C., et al.
Publicado: (2021)

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
por: Esteves, Sandro C., et al.
Publicado: (2019)

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
por: Esteves, Sandro C., et al.
Publicado: (2021)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

The POSEIDON stratification - moving from poor ovarian response to low prognosis
por: Roque, Matheus, et al.
Publicado: (2021)

The novel POSEIDON stratification of ‘Low prognosis patients in Assisted Reproductive Technology’ and its proposed marker of successful outcome
por: Humaidan, Peter, et al.
Publicado: (2016)

Low Prognosis by the POSEIDON Criteria in Women Undergoing Assisted Reproductive Technology: A Multicenter and Multinational Prevalence Study of Over 13,000 Patients
por: Esteves, Sandro C., et al.
Publicado: (2021)

Growth Hormone Cotreatment for Low-Prognosis Patients According to the POSEIDON Criteria
por: Liu, Xueying, et al.
Publicado: (2021)

Cumulative Live Birth Rates in Low Prognosis Patients According to the POSEIDON Criteria: An Analysis of 26,697 Cycles of in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Li, Yuan, et al.
Publicado: (2019)

Editorial: Rising stars in reproduction: 2021
por: Bedoschi, Giuliano
Publicado: (2023)

Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria
por: Grynberg, Michael, et al.
Publicado: (2019)

GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles—A Systematic PRISMA Review and Meta-analysis
por: Haahr, Thor, et al.
Publicado: (2017)

An Observational Retrospective Cohort Trial on 4,828 IVF Cycles Evaluating Different Low Prognosis Patients Following the POSEIDON Criteria
por: Levi-Setti, Paolo Emanuele, et al.
Publicado: (2019)

Management Strategies for POSEIDON's Group 1
por: Polyzos, Nikolaos P., et al.
Publicado: (2019)

Management Strategies for POSEIDON Group 2
por: Sunkara, Sesh Kamal, et al.
Publicado: (2020)

Cumulative Live Birth Rates of Good and Low Prognosis Patients According to POSEIDON Criteria: A Single Center Analysis of 18,455 Treatment Cycles
por: Shi, Wenhao, et al.
Publicado: (2019)

Comparison of Cumulative Live Birth Rates Between GnRH-A and PPOS in Low-Prognosis Patients According to POSEIDON Criteria: A Cohort Study
por: Zhang, Shaodi, et al.
Publicado: (2021)

Follicular Output Rate and Follicle-to-Oocyte Index of Low Prognosis Patients According to POSEIDON Criteria: A Retrospective Cohort Study of 32,128 Treatment Cycles
por: Chen, Lijuan, et al.
Publicado: (2020)

The Effect of Growth Hormone on the Clinical Outcomes of Poor Ovarian Reserve Patients Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection Treatment: A Retrospective Study Based on POSEIDON Criteria
por: Cai, Mei-hong, et al.
Publicado: (2019)

Reply: The low responder according to the POSEIDON criteria: is the prognosis really poor?
por: Leijdekkers, Jori A, et al.
Publicado: (2019)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Bühler, Klaus F.
Publicado: (2020)

Commentary: Management Strategies for POSEIDON Groups 3 and 4
por: Fischer, Robert, et al.
Publicado: (2020)

Update on the management of poor ovarian response in IVF: the shift from Bologna criteria to the Poseidon concept
por: Drakopoulos, Panagiotis, et al.
Publicado: (2020)

Predictive Factors for Live Birth in Fresh In Vitro Fertilization/Intracytoplasmic Sperm Injection Treatment in Poor Ovarian Reserve Patients Classified by the POSEIDON Criteria
por: Li, Fei, et al.
Publicado: (2021)

Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients
por: Esteves, Sandro C, et al.
Publicado: (2021)

Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification
por: Grisendi, Valentina, et al.
Publicado: (2019)

Bisphenol A-Induced Epigenetic Changes and Its Effects on the Male Reproductive System
por: Cariati, Federica, et al.
Publicado: (2020)

Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker—The Follicle-To-Oocyte (FOI) Index
por: Alviggi, Carlo, et al.
Publicado: (2018)

Management of Women With an Unexpected Low Ovarian Response to Gonadotropin
por: Conforti, Alessandro, et al.
Publicado: (2019)

The Future of Cryopreservation in Assisted Reproductive Technologies
por: Bosch, Ernesto, et al.
Publicado: (2020)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
por: Conforti, Alessandro, et al.
Publicado: (2021)

Comparison of ART outcome in patients with poor ovarian response according to POSEIDON criteria
por: Lee, Hyun Joo, et al.
Publicado: (2022)

The Interplay Between Prolactin and Reproductive System: Focus on Uterine Pathophysiology
por: Auriemma, Renata S., et al.
Publicado: (2020)

Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria
por: Li, Fei, et al.
Publicado: (2020)

Co-Administration of Clomiphene Citrate and Letrozole in Mild Ovarian Stimulation Versus Conventional Controlled Ovarian Stimulation Among POSEIDON Group 4 Patients
por: Lin, Hsin-Ta, et al.
Publicado: (2022)

Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study
por: Yan, Enqi, et al.
Publicado: (2023)

Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
por: Orvieto, Raoul, et al.
Publicado: (2021)

The Role of Traditional Chinese Formula Ding-Kun Pill (DKP) in Expected Poor Ovarian Response Women (POSEIDON Group 4) Undergoing In Vitro Fertilization-Embryo Transfer: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
por: Song, Jing-Yan, et al.
Publicado: (2021)

Growth Hormone and Reproduction: Lessons Learned From Animal Models and Clinical Trials
por: Dosouto, Carlos, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_l1a5b77itoe6qqhal1kb96b95h